Comparing new microbial enzyme to standard pancreatic enzyme therapy for chronic pancreatitis
Part of Digestive system clinical trials.
This study tests if a new microbial-based pancreatic enzyme works as well as the standard pig-derived enzyme for people with chronic pancreatitis who have trouble digesting food. Participants will take either the new or standard treatment for a period to compare how well it improves digestion and symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have chronic pancreatitis with signs of digestive problems.
- Your last stool test shows a low level of pancreatic elastase, below 100.
- You have symptoms of poor digestion, like weight loss, oily stools, or belly pain.
- You can stop taking pancreatic enzymes for 2 weeks before the study begins.
- You are willing to take the study pills for the duration of the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new digestive enzyme supplement (NHS7108) in adults whose pancreas doesn't make enough enzymes to digest food properly. The trial evaluates whether this new treatment is safe and helps improve fat digestion better than current treatments.
This trial tests a new medicine (ANG003) for people with cystic fibrosis who have severe pancreatic problems. It looks at how safe and effective the medicine is, and whether it helps with digestion.
This trial tests whether a pancreatic enzyme replacement therapy (PERT) can help people who still have digestive problems after a recent episode of acute pancreatitis. The goal is to see if it improves symptoms like stomach pain, bloating, or diarrhea.
This trial tests a new blood test to measure how well your pancreas works. It may help people with chronic pancreatitis understand their condition and quality of life.
This study tests whether adding pancreatic digestive enzymes to tube feeding can improve digestion and outcomes in critically ill adults who have higher risk of not producing enough digestive enzymes. If you qualify, you may receive the enzyme supplement or a comparison treatment while you’re in the ICU.
This study tests a protein drink with digestive enzymes for people with chronic pancreatitis who are underweight. It aims to help improve nutrition and weight.
Hear when a new Pancreatitis, Chronic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.